Genetic factors influencing the metabolism of tolbutamide
- PMID: 2519343
- DOI: 10.1016/0163-7258(89)90064-8
Genetic factors influencing the metabolism of tolbutamide
Similar articles
-
CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.Drug Metab Dispos. 2000 Mar;28(3):354-9. Drug Metab Dispos. 2000. PMID: 10681382
-
Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.Drug Metab Dispos. 1990 May-Jun;18(3):356-61. Drug Metab Dispos. 1990. PMID: 1974199
-
Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.Drug Metab Dispos. 2000 Jan;28(1):38-43. Drug Metab Dispos. 2000. PMID: 10611138
-
Polysaccharide peptides from Coriolus versicolor competitively inhibit tolbutamide 4-hydroxylation in specific human CYP2C9 isoform and pooled human liver microsomes.Phytomedicine. 2011 Oct 15;18(13):1170-5. doi: 10.1016/j.phymed.2011.06.002. Epub 2011 Jul 14. Phytomedicine. 2011. PMID: 21757329
-
Roles of two allelic variants (Arg144Cys and Ile359Leu) of cytochrome P4502C9 in the oxidation of tolbutamide and warfarin by human liver microsomes.Xenobiotica. 1998 Feb;28(2):103-15. doi: 10.1080/004982598239614. Xenobiotica. 1998. PMID: 9522436
Cited by
-
Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily.Biochem J. 1993 Jan 15;289 ( Pt 2)(Pt 2):533-8. doi: 10.1042/bj2890533. Biochem J. 1993. PMID: 8424795 Free PMC article.
-
Co-regulation of phenytoin and tolbutamide metabolism in humans.Br J Clin Pharmacol. 1992 Dec;34(6):494-8. Br J Clin Pharmacol. 1992. PMID: 1493081 Free PMC article.
-
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.Br J Clin Pharmacol. 1998 Jun;45(6):525-38. doi: 10.1046/j.1365-2125.1998.00721.x. Br J Clin Pharmacol. 1998. PMID: 9663807 Free PMC article. Review.
-
A study of the potential effect of sertraline on the pharmacokinetics and protein binding of tolbutamide.Clin Pharmacokinet. 1997;32 Suppl 1:31-6. doi: 10.2165/00003088-199700321-00005. Clin Pharmacokinet. 1997. PMID: 9068933 Clinical Trial.
-
Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.Br J Clin Pharmacol. 2005 Nov;60(5):508-18. doi: 10.1111/j.1365-2125.2005.02483.x. Br J Clin Pharmacol. 2005. PMID: 16236041 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources